J0391 HCPCS code: Injection, artesunate, 1 mg
J0391 is the HCPCS Level II code for injection, artesunate, 1 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 770 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-01-01 |
| Last action effective | 2024-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 770 | CMS Policy |
| practitioner claims | 770 | CMS Policy |
What changed for J0391
- 2024-01-01: J0391 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0391?
J0391 is the HCPCS Level II code for injection, artesunate, 1 mg. Short descriptor: "Inj, artesunate, 1mg".
Does Medicare cover J0391?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0391 can be billed per day?
770 on outpatient hospital claims; 770 on practitioner claims (NCCI medically unlikely edits).
Related J03 codes
- J0300 — Injection, amobarbital, up to 125 mg
- J0330 — Injection, succinylcholine chloride, up to 20 mg
- J0348 — Injection, anidulafungin, 1 mg
- J0349 — Injection, rezafungin, 1 mg
- J0350 — Injection, anistreplase, per 30 units
- J0360 — Injection, hydralazine hcl, up to 20 mg
- J0364 — Injection, apomorphine hydrochloride, 1 mg
- J0365 — Injection, aprotonin, 10,000 kiu
- J0380 — Injection, metaraminol bitartrate, per 10 mg
- J0390 — Injection, chloroquine hydrochloride, up to 250 mg
- J0395 — Injection, arbutamine hcl, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0391
- Watch J0391 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0391
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.